OS Therapies Inc 2025年季度报告
Intra-Cellular Therapies Inc 2024年度报告
AK112 to validate its potential as next-generation IO therapy
BioRestorative Therapies Inc 2024年度报告
Taysha Gene Therapies Inc 2024年度报告
Medical Rationale Supporting Patient Access To Novel Oncology Combination Therapies
Considerations for the use of anthelminthic therapy for the treatment of neurocysticercosis
Access to oncology combination therapies in Europe moving forward